MELD Na (UNOS/OPTN)

ورودی‌های بالینی بیمار

حداقل ۰.۰۱ — حداکثر ۴۰ • واحد: mg/dL

حداقل ۰.۰۱ — حداکثر ۱۰۰ • واحد: mg/dL

حداقل ۰.۰۱ — حداکثر ۱۰۰

حداقل ۱۰۰ — حداکثر ۱۵۰ • واحد: mEq/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
meld na score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk6–9
  • Moderate Risk10–19
  • High Risk20–29
  • Very High Risk30–39
Direct Clinical Answer

The MELD Na (UNOS/OPTN) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include creatinine. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016

Clinical Indication

The MELD Na (UNOS/OPTN) is indicated for bedside clinical practice to support Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.

Formula & Variables:

MELD(i) = 0.957 × ln(Cr) + 0.378 × ln(bilirubin) + 1.120 × ln(INR) + 0.643, then if MELD(i) > 11: MELD Na = MELD(i) + 1.32 × (137 - Na) - [0.033 × MELD(i) × (137 - Na)]

Input Parameters

NameTypeRequiredDescription
creatininefloatYesSerum creatinine in mg/dL. If patient on dialysis ≥2 times in past week, use 4.0. If <1.0, use 1.0(mg/dL)
bilirubinfloatYesTotal bilirubin in mg/dL. If <1.0, use 1.0(mg/dL)
inrfloatYesInternational Normalized Ratio (INR). If <1.0, use 1.0
sodiumfloatYesSerum sodium in mEq/L. Values <125 are set to 125, values >137 are set to 137(mEq/L)
dialysis_twice_past_weekstringYesHas the patient had dialysis (hemodialysis, peritoneal dialysis, CVVHD) at least twice in the past week?

Score Interpretation & Guidance

RangeStageDescription
6–9Low RiskMELD Na ≤9
10–19Moderate RiskMELD Na 10-19
20–29High RiskMELD Na 20-29
30–39Very High RiskMELD Na 30-39
40–40Extremely High RiskMELD Na ≥40

Evidence-Based References (EBM)

  • Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.DOI: 10.1056/NEJMoa0801209
  • Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563.DOI: 10.1002/hep.21563
  • OPTN Policy 9: Allocation of Livers and Liver-Intestines. Organ Procurement and Transplantation Network. Effective January 11, 2016.

Related calculators